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In This IssueIrreversible Inhibitor of CDK2
PAGE 1159
Irreversible inhibitors have a distinctive mode of action and offer an alternative
route to competitive ATP inhibitors to target protein kinases. Anscombe et al.
describe NU6300, a covalent CDK2 inhibitor that illustrates the potential of
using vinyl sulfones to mediate irreversible inhibition.
Tailor-Made Protein Scaffold
PAGE 1165
Watanabe et al. propose a segment-based combinatorial approach termed
adaptive assembly that generates a tailor-made protein scaffold for a given
functional peptide. Adaptive assembly can achieve significant functional
enhancement without relying on known protein structures.
Ponatinib and Regorafenib Inhibit Inflammatory
Signaling
PAGE 1174
Canning et al. report the structure of the diverse kinase RIPK2 and characterize its inhibition by the FDA-approved drugs po-
natinib and regorafenib. The inhibitors prevent the autophosphorylation and ubiquitination of RIPK2 upon NOD2 stimulation
and block downstream NFkB activation and inflammatory signaling.
Targeting Androgen Receptor in Prostate Cancer
PAGE 1185
KDM4 proteins are co-activators of androgen receptor (AR) andmay play a role in castration-resistant prostate cancer devel-
opment. Duan et al. identify several inhibitors of KDM4 and describe how they inhibit expression of genes critical for cell cycle
progression and tumor growth in vivo.
Analyzing MIF Structural Features
PAGE 1197
Pantouris et al. report the first detailed analysis of the MIF structural features that control activation of CD74. The knowledge
gained by this work provides the framework for the development of potent therapeutics that block MIF-CD74 interactions.Waking up the Guardian of the Genome
PAGE 1206
Hiraki et al. identify chetomin (CTM) as a mutant p53 R175H reactivator through
a cell-based high-throughput small molecule screening, which enabled trans-
activation of its target genes, and selectively inhibited the growth of cancer cells
with mutant p53 R175H. CTM binding to a chaperone protein Hsp40 causes a
potential conformation change of mutant p53 to wt-like p53.
Antibiotics Disassemble the Bacterial Division
Septum
PAGE 1217
Jacquier et al. demonstrate the presence of a functional chlamydial Tol-Pal
complex at the division septum, which is bound to chlamydial peptidoglycan and apparently plays an important role in the
maintenance of the bacterial membrane integrity.
Sulfotransferase Makes Cancer Killer out of Cabbage Compounds
PAGE 1228
Natural products indole-3-carbinols (I3Cs), commonly found in cruciferous vegetables, have an anti-proliferative effects in
cancer cells. Rothman et al. show that for one class of the synthetic derivatives of I3Cs, N-BICs, the first step in their mech-
anism of anti-cancer action is conversion to reactive nucleophiles mediated by SULT1A1.
Targeting Gut Microbiome to Eliminate Side-Effects of Chemotherapy
PAGE 1238
Wallace et al. elucidate the structure and function of enzymes from the major GI microbiome phyla that, when selectively
targeted by potent inhibitors, can uniquely control the side effects of a cancer chemotherapeutic.Chemistry & Biology 22, September 17, 2015 ª2015 Elsevier Ltd All rights reserved v
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PAGE 1250
Li et al. show that Escherichia coli membrane interaction and permeability of a designed proline-rich antimicrobial peptide,
Chex-Arg20, is significantly altered by its covalent multimerization. With an increase from monomer to tetramer, the mecha-
nism proceeds from membrane aggregation and non-lysis to membrane damage.
Search Algorithm Yields New Natural Products
PAGE 1259
Yang et al. report an automated untargeted informatic strategy to screen for variants in peptide natural product families. This
discovery strategy led to the identification of over 70 unreported variants, including one with greater potency.
Cultivating Uncultured Marine Bacteria
PAGE 1270
Choi et al. illustrate that low nutrient media and long incubation times lead to the isolation of rare, previously unculturedmarine
bacteria that produce new antibacterial metabolites. Their work demonstrates that unique marine bacteria are easier to culti-
vate than previously suggested.vi Chemistry & Biology 22, September 17, 2015 ª2015 Elsevier Ltd All rights reserved
